NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 326 filers reported holding NATERA INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,657 | +27.3% | 52,240 | +7.5% | 0.02% | +20.0% |
| Q1 2024 | $4,445 | +49.0% | 48,599 | +2.0% | 0.02% | +42.9% |
| Q4 2023 | $2,984 | +48.3% | 47,639 | +4.8% | 0.01% | +27.3% |
| Q3 2023 | $2,012 | -8.6% | 45,469 | +0.5% | 0.01% | -8.3% |
| Q2 2023 | $2,201 | -7.2% | 45,239 | +5.9% | 0.01% | -7.7% |
| Q1 2023 | $2,371 | +39.2% | 42,699 | +0.7% | 0.01% | +30.0% |
| Q4 2022 | $1,703 | -99.9% | 42,399 | +14.7% | 0.01% | -9.1% |
| Q3 2022 | $1,620,000 | +25.2% | 36,969 | +1.3% | 0.01% | +37.5% |
| Q2 2022 | $1,294,000 | +3.4% | 36,499 | +18.7% | 0.01% | +14.3% |
| Q1 2022 | $1,251,000 | -55.7% | 30,744 | +1.6% | 0.01% | -53.3% |
| Q4 2021 | $2,826,000 | -15.6% | 30,259 | +0.7% | 0.02% | -21.1% |
| Q3 2021 | $3,350,000 | +8.4% | 30,059 | +10.4% | 0.02% | +5.6% |
| Q2 2021 | $3,091,000 | – | 27,230 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 503,094 | $54,480,049 | 52.98% |
| Kynam Capital Management, LP | 2,014,408 | $218,140,242 | 16.83% |
| Eagle Health Investments LP | 474,114 | $51,341,805 | 9.00% |
| Sofinnova Investments, Inc. | 1,550,280 | $167,879,821 | 8.72% |
| Eversept Partners, LP | 1,173,494 | $127,077,665 | 8.70% |
| Lagoda Investment Management, L.P. | 130,195 | $14,098,817 | 8.11% |
| Duquesne Family Office | 1,974,880 | $213,860 | 7.33% |
| Tri Locum Partners LP | 230,585 | $24,970,050 | 6.31% |
| PERKINS CAPITAL MANAGEMENT INC | 57,550 | $6,232 | 5.87% |
| PURA VIDA INVESTMENTS, LLC | 67,500 | $7,309,575 | 4.63% |